MIRA INFORM
REPORT
|
Report Date : |
02.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
SANDOZ GMBH |
|
|
|
|
Formerly Known As : |
Biochemie GmbH |
|
|
|
|
Registered Office : |
Biochemiestraße 10, A-6250 Kundl |
|
|
|
|
Country : |
Austria |
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
26.11.1965 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical preparations |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
EUR 28.140.000,00 |
|
|
|
|
Status : |
Very Good |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Austria |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Basic company information
|
Company name: |
Sandoz GmbH |
|
Status: |
active company |
|
Locations: |
Biochemiestraße 10, A-6250 Kundl |
|
Phone: |
0043 (5338) 200 |
|
Fax: |
0043 (5338) 200 - 415 |
|
E-mail: |
info.sandoz@gx.novartis.com |
|
Internet: |
http://www.sandoz.com |
|
Activities: |
Önace 21200 100% Manufacture of pharmaceutical
preparations |
|
|
|
|
General Assessment: |
|
|
|
Recommendation We recommends to establish a business and credit
relationship, and to benefit from arising business opportunities. |
|
|
|
|
Detail Assessment: |
Payments are sometimes made using cash discounts or
according to conditions. |
|
|
Financial situation is good. |
|
|
Maximum credit EUR
28.140.000,00 |
Additional company information
|
Year of incorporation: |
1965 |
|
||||
|
Type of company: |
Manufacturing |
|
||||
|
Legal form: |
limited liability company since 1965-11-18 |
|
||||
|
companies' house number: |
FN 50587 v Innsbruck 1965-11-26 |
|
||||
|
Activities: |
|
|
||||
|
ARA-number: |
3462 |
|
||||
|
VAT number: |
ATU 32425809 |
|
||||
|
number - Austrian National Bank: |
4812 |
|
||||
|
|
|
|||||
|
|
||||||
|
Export |
Country |
|
|
|
||
|
Export |
world-wide |
|
2011 |
|
||
Financial data
|
total turnover (total sales) |
2010 |
EUR 1.340.000.000,00 |
(approx.) |
|
total turnover (total sales) |
2009 |
EUR 1.315.733.905,62 |
(exact) |
|
total turnover (total sales) |
2008 |
EUR 1.263.133.197,81 |
(exact) |
|
total turnover (total sales) |
2007 |
EUR 1.300.456.268,63 |
(exact) |
|
total turnover (total sales) |
2006 |
EUR 1.184.320.694,21 |
(exact) |
|
total employees |
2011 |
2900 |
(approx.) |
|
total investments |
2008 |
EUR 103.228.274,06 |
(exact) |
Extraxt from the Companies' House
|
firm
(style): |
|
63
Sandoz GmbH |
|
legal
form: |
|
1
Gesellschaft mit beschränkter Haftung |
|
registered
office: |
|
1
politischer Gemeinde Kundl |
|
business
adress: |
|
15
Biochemiestraße 10 |
|
capital: |
|
52
EUR 32.703.000 |
|
reference
date annual accounts: |
|
1
31. Dezember |
|
annual
accounts: |
|
116
zum 31.12.2009 eingereicht am 19.11.2010 |
|
power
of representation: |
|
1
Die Gesellschaft wird, wenn mehrere Geschäftsführer |
|
other provisions: |
|
8
Der Aufsichtsrat besteht aus sechs Mitgliedern. |
|
proxy: |
|
CS
Dr. Elmar Dolejsi, geb. 12.10.1960 |
|
supervisory
board: |
|
C
Dipl.-Ing.Dr. Heinrich Scherfler, geb. 25.08.1945 |
|
managing
director: |
|
AU
Mag. Richard Kronbichler, geb. 05.11.1952 |
|
shareholder: |
|
CM
Novartis Holding AG |
|
general table: |
|
Landesgericht Innsbruck |
Real estate
|
Registration number of real
estate 100 Cadastral register 83108 Kundl T
Number and date of entry 2463/2009 Status of 2011-03-22 |
|
Part
A - type of real estate : |
|
GST-NR
G BA (NUTZUNG)
FLäCHE GST-ADRESSE |
|
Part
B - ownership details : |
|
1 ANTEIL: 1/1 |
|
Part
C - registered charges : |
|
3
a 1589/1993 |
Private data
|
Surname |
Date of birth |
Address |
Executive positions |
Further executive positions (as
registered in the companies' house) |
|
Dr. Peter Gasteiger |
1972-06-30 |
6250 Kundl Biochemiestraße 10 |
manager, head of personnel |
0 |
|
Mag. Hubert Hirzinger |
1957-05-10 |
6250 Kundl Biochemiestraße 10 (p/A Sandoz GmbH) |
manager |
5 |
|
Mag. Richard Kronbichler |
1952-11-05 |
6341 Ebbs Oberndorf 50 d |
manager |
0 |
|
Dipl-Ing. Ernst Meijinders |
1956-12-14 |
6250 Kundl Biochemiestraße 10 |
manager |
0 |
|
Dr. Günter Stempfer |
1965-12-09 |
6250 Kundl Biochemiestraße 10 |
manager |
0 |
|
Mag. Hannes Teißl |
1965-02-03 |
6250 Kundl Biochemiestraße 10(c/o) |
manager |
0 |
|
Mag. Hans Peter Amon |
1975-01-19 |
6250 Kundl Biochemiestraße 10(c/o) |
joint signing clerk, head of accounting |
6 |
|
Dr. Elmar Dolejsi |
1960-10-12 |
6250 Kundl Biochemiestraße 10(c/o) |
joint signing clerk |
2 |
|
Sibylla Härtel |
1962-10-21 |
6250 Kundl Biochemiestraße 10(c/o) |
joint signing clerk |
0 |
|
Dr. Maria Schmalzl |
1960-08-11 |
6236 Alpbach Nr. 637 |
joint signing clerk |
1 |
|
|
Hausfrau |
|||
|
Mag. Ingrid Schwarzenberger |
1958-03-20 |
6250 Kundl Biochemiestraße 10(c/o) |
joint signing clerk |
0 |
|
Dr. Gerhard van-der-Meij |
1968-08-19 |
1020 Wien Stella Klein Löwweg 17 |
joint signing clerk |
1 |
|
Mag. Christian Seiwald |
1952-10-02 |
6250 Kundl Biochemiestraße 10(c/o) |
chairman of the supervisory board |
0 |
|
Christina Ackermann-Swistara |
1965-01-13 |
83607 Holzkirchen Industriestraße 25 |
deputy chairman of the supervisory board |
0 |
|
Barbara Nerad |
1962-12-30 |
6250 Kundl Biochemiestraße 10 |
member of the supervisory board |
0 |
|
Helmut Pancheri |
1961-07-05 |
6250 Kundl Biochemiestraße 10(c/o) |
member of the supervisory board |
0 |
|
Dr. Gerhard Schaefer |
1950-11-20 |
83607 Holzkirchen Industriestraße 25 |
member of the supervisory board |
0 |
|
Dipl-Ing.Dr. Heinrich Scherfler |
1945-08-25 |
6233 Kramsach Nr. 488f |
member of the supervisory board |
1 |
|
Mag. Max Leitinger |
|
6250 Kundl Biochemiestraße 10(c/o) |
head of EDP |
0 |
|
Josef Postl |
|
6250 Kundl Biochemiestraße 10(c/o) |
technical director |
0 |
Balance Sheet
(absolute) all amounts in EUR
|
|
2009-12-31 |
|
Franchises, patents, licences, trademarks and similar
rights and advantages |
14.446.771,51 |
|
Sum intangible assets |
14.446.771,51 |
|
Land and leasehold rights with buildings thereon including
building on land owned by third parties |
234.295.034,68 |
|
Technical plants and machines |
154.575.861,69 |
|
Advanced payments and constructions in progress |
14.806.179,36 |
|
Sum tangible assets |
415.020.027,51 |
|
Shares on related firms |
35.906.602,18 |
|
Other shareholdings |
1.751.901,77 |
|
Other financial assets, values and securities of fixed
assets |
14.644.676,78 |
|
Sum financial assets |
52.303.180,73 |
|
Sum fixed assets |
481.769.979,75 |
|
Raw-, auxiliary materials and supplies |
59.906.747,87 |
|
Unfinished products |
153.471.475,44 |
|
Finished products |
45.661.767,31 |
|
Advanced payments |
-319.451,67 |
|
Sum stock |
258.720.538,95 |
|
Claims from delivered goods and performed services |
120.963.991,22 |
|
Other claims and assets |
88.916.497,36 |
|
Claims against companies with shareholding relationship |
1.707.250,45 |
|
Claims against related firmes Claims against companies
with shareholding relationship |
137.775.799,92 |
|
Sum claims |
349.363.538,95 |
|
Cash on hand, cheques and bank deposits |
602.156,61 |
|
Sum cash and bank |
602.156,61 |
|
Sum current assets |
608.686.234,51 |
|
Deferred charges |
500.424,54 |
|
Sum deferred charges |
500.424,54 |
|
Assets |
1.090.956.638,80 |
|
Subscribed/declared capital |
32.703.000,00 |
|
Legal reserves |
3.270.300,00 |
|
Free reserves |
59.656.425,77 |
|
Balance sheet profit/balance sheet loss |
0,00 |
|
Sum equity capital |
95.629.725,77 |
|
Valuation reserves due to special depreciations and |
20.773.598,24 |
|
Sum reserves before taxes |
20.773.598,24 |
|
Investment contributions |
873.558,34 |
|
Sum floor capital |
873.558,34 |
|
Reservesfor severance pays |
34.046.553,41 |
|
Reserves for pensions |
47.986.153,73 |
|
Other reserves |
61.222.968,22 |
|
Sum reserves |
143.255.675,36 |
|
Liabilities against credit institutes |
152.252.247,81 |
|
Received advanced payments for orders |
924.532,71 |
|
Liabilities from delivered goods and performed services from
the acceptance of drafts and emission of promissory notes |
82.500.826,35 |
|
Liabilities against related firms |
561.853.366,29 |
|
Liabilities against firm with shareholding relationship |
2.998.803,64 |
|
Other liabilities |
25.788.187,85 |
|
Other loans |
3.485.200,00 |
|
Sum liabilities |
829.803.164,65 |
|
Deferred income |
620.916,44 |
|
Sum deferred income |
620.916,44 |
|
Liabilities |
1.090.956.638,80 |
|
Contingent liabilities |
9.100.000,00 |
|
Balance sheet sum |
1.090.956.638,80 |
P / L Account
(absolute) all amounts in
EUR
|
|
2009-12-31 |
|
Gross sales |
1.315.733.905,62 |
|
Increase or decrease in finished and unfinished goods and
in service claims |
87.133.937,56 |
|
Other manufacturing costs capitalized |
4.578.866,20 |
|
Sum turnover or sum gross profit |
1.407.446.709,38 |
|
Profits from retirement of fixed assets, except financial
assets |
29.283,33 |
|
Income from dissolution of reserves |
701.738,78 |
|
Other operating profits |
28.120.743,73 |
|
Other operating profits totally |
28.851.765,84 |
|
Costs for obtained services |
-23.717.138,43 |
|
Special account material costs |
-798.915.409,53 |
|
Costs for obtained services totally |
-822.632.547,96 |
|
Wages |
-24.449.020,66 |
|
Salaries |
-112.680.203,00 |
|
Costs for severance pays |
-2.754.541,57 |
|
Costs for old age pension |
-8.548.179,30 |
|
Legal fringe benefits and other payments depending on
salaries |
-37.152.173,33 |
|
Other social fringe benefits |
-4.624.375,55 |
|
Personnel expenses totally |
-190.208.493,41 |
|
Depreciation of intangible assets, tangible
assets,activated expenses for the set up and expansion of business
operation |
-81.783.907,41 |
|
Depreciation tangible assets / intangible assets
totally |
-81.783.907,41 |
|
Different operating costs |
-208.619.416,39 |
|
Other taxes |
-382.324,43 |
|
Other operating costs totally |
-209.001.740,82 |
|
Operating result totally |
132.671.785,62 |
|
Profits from shareholdings |
13.981.764,73 |
|
Income from other securities and loans of financial
assets |
807.370,49 |
|
Interest income, securties income and similar income |
51.860,13 |
|
Disbursements from other financial assets and from securities
of current assets (e.g. depreciations) |
-4.000.000,00 |
|
Interest and similar disbursements |
-12.815.911,24 |
|
Financial profits totally |
-1.974.915,89 |
|
Results from usual business activity
totally |
130.696.869,73 |
|
Taxes on income and profits |
-265.353,96 |
|
Taxes on income and profits totally |
-265.353,96 |
|
Annual surplus/annual deficit
totally |
130.431.515,77 |
|
Dissolution reserves before taxes |
1.116.426,63 |
|
Dissolution capital reserves |
4.000.000,00 |
|
Transfer to reserves before taxes |
-4.640.056,28 |
|
Reserves movements totally |
476.370,35 |
|
Annual profit/annual loss
totally |
130.907.886,12 |
|
Transfer of profit/overcounting of losses from ontract of
profit transfer |
-130.907.886,12 |
|
Transfer of profits totally |
-130.907.886,12 |
|
B/S profit/ B/S loss from profit and
loss account |
0,00 |
Key ratios
|
|
2009 |
|
Cash flow II |
212.215.423,18 |
|
Debt amortisation period |
4,57 |
|
Bank indebtedness |
14,27 |
|
Equity capital share |
10,75 |
|
Social capital share |
7,51 |
|
Fixed assets coverage |
41,37 |
|
Net profit ratio |
9,28 |
|
Capital turnover |
1,29 |
|
Return on investment |
13,15 |
|
Cash flow in % of operating performance |
15,07 |
|
Cash flow I |
212.480.777,14 |
|
Gross productivity |
7,39 |
|
Net productivity |
3,07 |
|
Operating performance |
1.407.446.709,38 |
|
Inventories in % of operating performance |
18,38 |
|
Gross profit |
584.814.161,42 |
Locations
|
Type |
Locations |
Description |
|
|
|
E-mail |
|
operational |
Biochemiestraße 10, A-6250 Kundl |
registered office |
|
|
|
|
|
operational |
Biochemiestraße 10, A-6250 Kundl |
registered headquarters, owned property |
|
|
|
info.sandoz@gx.novartis.com |
|
operational |
Brunnerstraße 59, A-1230 Wien |
branch office, rented premises |
|
|
|
|
|
operational |
Schaftenau Biochemiestraße 10, A-6330 Kufstein |
factory, owned property |
|
|
|
|
|
operational |
Dr. Hans Bachmannstraße 7, A-6250 Kundl, (umben.auf
Biochemiestraße 10) |
registered headquarters |
|
|
|
|
|
former |
Wagramerstraße 19, A-1220 Wien |
branch office |
|
|
|
|
related companies
|
Company name |
Postal code |
Stake in % |
|
Companies House |
|
Shares in this company are
held by: |
||||
|
Novartis Austria GmbH |
Stella Klein Löwweg 17, A-1020 Wien |
99.99 % 2006-07-27 |
|
FN 274620 d |
|
Novartis Holding AG |
Lichtstraße 35, CH-4056 Basel |
0.01 % 1997-02-22 |
|
|
|
|
||||
|
This company holds 100% of the
shares in: |
||||
|
HEXAL PHARMA GmbH |
Stella Klein Löw Weg 17, A-1020 Wien |
100 % 2005-12-17 |
|
FN 44896 z |
|
Novartis Institutes for Biomedical Research GmbH |
Brunnerstraße 59, A-1235 Wien |
100 % 1993-08-13 |
|
FN 43251 f |
|
Novartis Animal Health GmbH |
Biochemiestraße 10, A-6250 Kundl |
100 % 1996-12-03 |
|
FN 152616 k |
|
|
||||
|
This company holds 50% to 99%
of the shares in: |
||||
|
Biozym GmbH |
Biochemiestraße 10, A-6250 Kundl |
51 % 1993-12-17 |
|
FN 47953 w |
|
|
||||
|
Affiliated companies and
further participations: |
||||
|
Novartis Pharma GmbH |
Stella Klein Löwweg 17, A-1020 Wien |
|
|
FN 41622 i |
|
Nabriva Therapeutics AG |
Leberstraße 20, A-1112 Wien |
|
|
FN 269261 y |
|
Novartis Pharma GmbH |
Stella Klein Löwweg 17, A-1020 Wien |
|
|
FN 41622 i |
|
CIBA Vision GmbH |
Stella Klein Löwweg 17, A-1020 Wien |
|
|
FN 82357 p |
|
EBEWE Spezial-Pharma Holding GmbH |
Stella Klein Löwweg 17, A-1020 Wien |
|
|
FN 331193 z |
|
Austrian Center of Biopharmaceutical Technology |
Muthgasse 18, A-1190 Wien |
|
|
|
|
Novartis Institutes for BioMedical Research GmbH & Co
KG |
Brunnerstraße 59, A-1235 Wien |
2004-10-23 |
|
FN 253505 b |
Bankers
|
Banker |
Bank sort code |
Type of banking connection |
|
UniCredit Bank Austria AG, 1011 Wien |
12000 |
main bank connection |
Historical development
|
Year of incorporation: |
1965 |
|
Date of registration: |
1965-11-26 |
|
Change of company name: |
||
|
From |
To |
Company name |
|
|
2003-05-02 |
Biochemie GmbH |
|
2003-05-02 |
|
Sandoz GmbH |
|
Change in share capital: |
||
|
From |
To |
Capital |
|
|
2001-10-05 |
ATS 450.000.000,00 |
|
2001-10-05 |
|
EUR 32.703.000,00 |
|
Former executives: |
|||
|
From |
To |
Function |
Name |
|
1993-09-23 |
2010-03-19 |
joint signing clerk |
Mag. Friedrich Fuchs |
|
2008-05-29 |
2010-06-18 |
joint signing clerk |
Dipl-Betriebsw. Björn Komischke |
|
2006-06-23 |
2011-02-10 |
joint signing clerk |
Mag. Helmuth Hofer |
|
1993-05-10 |
1997-05-16 |
chairman of the supervisory board |
Dr. Urs Bärlocher |
|
1997-05-16 |
1998-04-18 |
chairman of the supervisory board |
Pierre Douaze |
|
1998-04-18 |
1999-10-12 |
chairman of the supervisory board |
Dr. Argeric Karabelas |
|
1999-10-12 |
2001-10-02 |
chairman of the supervisory board |
Dipl-Ing.Dr. Oswald Sellemond |
|
2001-10-02 |
2002-05-30 |
chairman of the supervisory board |
Mag. Christian Seiwald |
|
2002-05-30 |
2005-04-19 |
chairman of the supervisory board |
Mag. Christian Seiwald |
|
2005-04-19 |
2009-02-19 |
chairman of the supervisory board |
Dr. Andreas Rummelt |
|
2009-02-19 |
2010-07-29 |
chairman of the supervisory board |
Dr. Horst Uwe Groh |
|
1995-06-21 |
1997-05-16 |
deputy chairman of the supervisory board |
Dr. Daniel Vasella |
|
1999-10-12 |
2000-11-30 |
deputy chairman of the supervisory board |
Dr. Argeric Karabelas |
|
1997-05-16 |
2002-03-12 |
deputy chairman of the supervisory board |
Dr. Jörg Reinhardt |
|
2000-11-30 |
2002-05-30 |
deputy chairman of the supervisory board |
Thomas Ebeling |
|
2002-05-30 |
2005-04-19 |
deputy chairman of the supervisory board |
Paul Choffat |
|
2005-04-19 |
2010-07-29 |
deputy chairman of the supervisory board |
Mag. Christian Seiwald |
|
|
1997-05-16 |
member of the supervisory board |
Dr. Raymund Breu |
|
1998-01-27 |
2002-04-25 |
joint signing clerk |
Mag. Vinzenz Plörer |
|
1997-11-07 |
2002-10-01 |
joint signing clerk |
Dr. Helmut Deimel |
|
1999-04-15 |
2003-03-19 |
joint signing clerk |
Mag. Gerhard Hörl |
|
1993-09-23 |
2003-04-29 |
joint signing clerk |
Mag. Bernhard Sigl |
|
1999-08-17 |
2003-04-29 |
joint signing clerk |
Mag.Dr. Franz Stumpf |
|
2001-10-02 |
2003-12-18 |
joint signing clerk |
Dr. Johannes Gerstenbauer |
|
|
1999-04-13 |
manager |
Dipl-Ing.Dr. Oswald Sellemond |
|
|
2003-04-29 |
manager |
Werner Meßner |
|
2003-04-29 |
2004-09-01 |
manager |
Mag.Dr. Franz Stumpf |
|
2003-04-29 |
2005-07-28 |
manager |
Mag. Hubert Hirzinger |
|
2003-04-29 |
2005-07-28 |
manager |
Dr. Patrick Vink |
|
|
2006-06-03 |
manager |
Dipl-Ing.Dr. Heinrich Scherfler |
|
2004-09-01 |
2007-06-06 |
manager |
Mag. Johannes Schwertner |
|
2003-04-29 |
2008-02-21 |
manager |
Mag. Bernhard Sigl |
|
2008-02-21 |
2010-02-20 |
manager |
Dipl-Ing. Bianca Stöhr |
|
1993-09-23 |
1999-02-16 |
joint signing clerk |
Dr. Paul Inama Sternegg |
|
1998-10-20 |
1999-04-15 |
joint signing clerk |
Eric Gorka |
|
1993-09-23 |
2000-09-13 |
joint signing clerk |
Dr. Otto Streichsbier |
|
1993-09-23 |
2000-10-11 |
joint signing clerk |
Mag. Hubert Hirzinger |
|
1993-09-23 |
2001-03-13 |
joint signing clerk |
Dr. Eberhard Pirich |
|
1993-09-23 |
2001-10-02 |
joint signing clerk |
Dr. Walter Killiches |
|
1998-01-27 |
2003-12-18 |
joint signing clerk |
Mag. Gottfried Rieser |
|
2003-05-06 |
2004-11-03 |
joint signing clerk |
Mag. Siegfried Johann Leitner |
|
1998-02-02 |
2005-03-08 |
joint signing clerk |
Peter Haselböck |
|
1993-09-23 |
2005-03-08 |
joint signing clerk |
Dr. Ernst Leitner |
|
1998-01-27 |
2006-05-16 |
joint signing clerk |
Dr. Santiago Alonso Ciriza |
|
2004-08-10 |
2006-05-16 |
joint signing clerk |
Knut Ulrich Mager |
|
2000-03-14 |
2006-05-16 |
joint signing clerk |
Hans Schaller |
|
1993-09-23 |
2007-02-09 |
joint signing clerk |
Mag. Rupert Labner |
|
2006-06-23 |
2007-06-15 |
joint signing clerk |
Lorraine Lynne-Christina Perry |
|
2003-10-01 |
2007-06-15 |
joint signing clerk |
Mag.Dr. Otto Scheidl |
|
2002-07-17 |
2007-06-15 |
joint signing clerk |
Dr. Elisabeth Schneider Scherzer |
|
1998-04-02 |
2007-06-15 |
joint signing clerk |
Dr. Bruno Wallnöfer |
|
2000-01-12 |
2007-06-15 |
joint signing clerk |
Mag. Barbara Weigl Aman |
|
2004-10-06 |
2008-05-29 |
joint signing clerk |
Mag. Elgar Schnegg |
|
2000-05-31 |
2009-02-19 |
joint signing clerk |
Kurt Unterkircher |
|
2000-01-12 |
2010-01-09 |
joint signing clerk |
Dr. Josef Egerbacher |
|
|
1998-04-18 |
member of the supervisory board |
Daniel Wagniere |
|
1998-04-18 |
1999-08-06 |
member of the supervisory board |
Dr. Hans Kindler |
|
1997-05-16 |
1999-08-06 |
member of the supervisory board |
Dr. Erwin Schillinger |
|
1999-08-06 |
1999-10-12 |
member of the supervisory board |
Dipl-Ing.Dr. Oswald Sellemond |
|
1999-08-06 |
2001-10-02 |
member of the supervisory board |
Mag. Christian Seiwald |
|
2001-10-02 |
2002-05-30 |
member of the supervisory board |
Dipl-Ing.Dr. Oswald Sellemond |
|
2002-03-12 |
2005-07-14 |
member of the supervisory board |
Dr. Urs Bärlocher |
|
2005-07-14 |
2007-03-16 |
member of the supervisory board |
Kevin Plummer |
|
2002-05-30 |
2007-06-28 |
member of the supervisory board |
Dr. Erwin Schillinger |
|
1999-08-06 |
2008-08-01 |
member of the supervisory board |
Hermann Egger |
|
2007-06-28 |
2008-08-01 |
member of the supervisory board |
Dr. Peter Jager |
|
2008-08-01 |
2009-03-11 |
member of the supervisory board |
Knut Mager |
|
2009-03-11 |
2010-04-20 |
member of the supervisory board |
Dr. Andreas Rummelt |
|
2010-04-20 |
2010-07-29 |
member of the supervisory board |
Christina Ackermann Swistara |
|
2010-07-29 |
2010-09-22 |
member of the supervisory board |
Dr. Horst Uwe Groh |
|
|
1998-01-24 |
employee's representative on the supervisory board |
Johann Auer |
|
|
1999-08-06 |
employee's representative on the supervisory board |
Helmuth Stubenvoll |
|
Former shareholders: |
|||
|
From |
To |
Function |
Name |
|
|
1997-02-22 |
partner |
Sandoz Holding AG |
|
1997-02-22 |
2000-08-26 |
partner |
Novartis AG |
|
Former shareholdings: |
||
|
From |
To |
Name |
|
1996-05-08 |
1998-11-24 |
Novartis Handelsgesellschaft m.b.H. |
|
2004-09-16 |
2004-10-23 |
Novartis Forschungsinstitut GmbH |
|
2005-01-27 |
2005-10-06 |
Grandis Handel mit pharmazeutischen Produkten Gesellschaft
mbH |
|
2006-01-24 |
2007-11-10 |
Nabriva Therapeutics AG |
|
Mergers: |
||
|
Date |
Function |
Name |
|
2000-11-24 |
merged with |
Novartis Handelsgesellschaft m.b.H. |
|
2006-12-14 |
merged with |
Sandoz GmbH |
|
2005-10-06 |
merged with |
Grandis Handel mit pharmazeutischen Produkten Gesellschaft
mbH |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.05 |
|
UK Pound |
1 |
Rs.72.40 |
|
Euro |
1 |
Rs.63.46 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.